Andrew Medvedovsky, MD
Pain Medicine · Jacksonville, FLNPI 1649431594
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,000 of the $32,012 with a category attached, or 68.7%. 37 manufacturers reported payments, led by Vertos Medical, Inc. at 48.6% of the total. Reporting peaked in 2023 at $24,683 and has fallen 94.5% since, to $1,348 in 2025. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 320 payments — averaging $100.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$16K
- Spinal Simplicity, LLC$7K
- Boston Scientific$3K
- Nutech Spine, Inc.$3K
- Medtronic$2K
- Collegium Pharmaceutical, Inc.$566
- plus $2K from 31 others
What the payments were for
- Consulting fees$22,00069%
- Travel & lodging$1,3094%
- Food & beverage$8,70327%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 24 | $15,571 |
| Spinal Simplicity, LLC | 29 | $6,635 |
| Boston Scientific | 102 | $2,817 |
| Nutech Spine, Inc. | 1 | $2,500 |
| Medtronic(2 entities) | 31 | $1,539 |
| Collegium Pharmaceutical, Inc. | 30 | $566 |
| Nevro Corp. | 12 | $295 |
| Abbott | 14 | $293 |
| Foundation Fusion Solutions, LLC | 3 | $218 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $154 |
| Stimwave Technologies Incorporated | 13 | $146 |
| Si-bone, Inc. | 2 | $112 |
| Pfizer | 5 | $103 |
| AbbVie | 5 | $96 |
| GRT US Holding, Inc. | 4 | $89 |
| Globus Medical | 2 | $77 |
| Virtus Pharmaceuticals LLC | 4 | $73 |
| Scilex Pharmaceuticals Inc. | 4 | $69 |
| Relievant Medsystems, Inc. | 2 | $63 |
| Saluda Medical Americas, Inc. | 2 | $62 |
| Painteq LLC | 3 | $57 |
| Bioventus LLC | 3 | $52 |
| Alevio, LLC | 1 | $51 |
| Camber Spine Technologies LLC | 1 | $48 |
| Biodelivery Sciences International, Inc. | 3 | $42 |
| Johnson & Johnson | 1 | $39 |
| Zavation Medical Products, LLC | 1 | $37 |
| Biotronik NRO, Inc. | 1 | $30 |
| Vertex | 1 | $30 |
| Hydrocision, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Protega Pharmaceutials Inc | 1 | $23 |
| Redhill Biopharma Inc. | 1 | $17 |
| Curonix LLC | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Valinor Pharma, LLC | 1 | $14 |
| Convatec Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$15,415
- HA MINUTEMAN G3-R$6,086
- SiFix$2,500
- WaveWriter Alpha Prime 16$934
- INTELLIS$235
- INTELLIS ADAPTIVESTIM$232
- INCEPTIV$158
- VANTA ADAPTIVESTIM$147
- Omnia$140
- SYNCHROMEDII$128
How this compares
$32,012 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,488 | $79,252 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,879 | $69,394 |
| RelistorMethylnaltrexone Bromide | 22 | $51,575 |
| MovantikNaloxegol Oxalate | 70 | $28,404 |
| Xtampza ErOxycodone Myristate | 63 | $23,299 |
| Lidocaine | 157 | $17,419 |
| Gabapentin | 1,166 | $13,844 |
| Diclofenac Sodium | 169 | $11,992 |
| LinzessLinaclotide | 20 | $11,496 |
| Pregabalin | 508 | $10,367 |
| QuviviqDaridorexant Hcl | 19 | $9,163 |
| Oxycodone Hcl | 501 | $7,653 |
| Tizanidine Hcl | 638 | $7,027 |
| OxycontinOxycodone Hcl | 11 | $6,330 |
| Cyclobenzaprine Hcl | 545 | $6,242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $154 | $51,57522 claims |
| Redhill Biopharma Inc.Movantik | $17 | $28,40470 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $566 | $23,29963 claims |
| AbbVieLinzess | $96 | $11,49620 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine-Naloxone | $14 | $8,554119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Jacksonville
- Mark-Friedrich HurdleJacksonville$140K
- Orlando FloreteJacksonville$86K
- Christopher NetzelJacksonville$34K
- Sahil GuptaJacksonville$19K
- Pavel BalduyeuJacksonville$18K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Rodolfo GariTampa$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.